Strategic Advisory Groups

Every child deserves a champion—a voice to speak for them, a heart to fight for their future. Be that voice. Be that change.”

Rita Pierson

Make a Difference!

YOU can join EAP in transforming paediatric healthcare. As a paediatrician, your expertise and dedication are vital to the work of our Strategic Advisory Groups (SAGs). Collaborate with passionate professionals, contribute to groundbreaking initiatives, and play an active role in shaping policies that improve the lives of children worldwide.

It’s simple: scroll through the pages below, find your area of interest, and take the first step toward making a difference!

For any questions or guidance, contact us at secretariat@eapaediatrics.eu.

EAP Newsletter

Don’t forget to sign up for the EAP newsletter to stay informed about SAG activities and new opportunities.

List of the EAP strategic advisory groups

Adolescent Health and Medicine

Advocacy for Children

Choosing Wisely

Ethics

Rare Diseases

Vaccination

Past Activities

close menu icon

Your Enquiries Are Welcome

We will respond to you by Email

Core-MD Project

Coordinating Research and Evidence for Medical Devices (CORE-MD)

New ways to test high-risk medical devices.

 

Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.


It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.

EAP Representative:

  • BERTHOLD KOLETZKO
Read more